2 years ago
AMLX
AnalystsAndrew FeinAndrew Fein's Stock Forecasts
AnalystsAndrew Fein
Analyst Ranking
Top 1%
#8 out of 5213 analysts
Average Return
+24.32%
Win Rate
52%339 out of 652
Risk vs Reward
Poor
Good
Andrew Fein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings IncCRBP | +1,500.00% | $2.52 | $40.32 | 2023-03-07 - 2024-03-07 | Buy |
Palvella Therapeutics IncPVLA | +790.82% | $11.88 | $105.83 | 2024-12-25 - 2025-12-24 | Buy |
Palvella Therapeutics IncPVLA | +656.83% | $13.25 | $100.28 | 2025-01-02 - 2026-01-02 | Buy |
Corbus Pharmaceuticals Holdings IncCRBP | +570.73% | $3.28 | $22.00 | 2023-02-13 - 2024-02-13 | Buy |
Palvella Therapeutics IncPVLA | +561.49% | $13.97 | $92.41 | 2025-01-09 - 2026-01-09 | Buy |
Andrew Fein Analyst Color
Get additional color on Andrew Fein's coverage of popular stocks
Andrew Fein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals IncKALV | 17 | Buy | $37.00 | +100.65% | Maintains | 2 months ago |
Amylyx Pharmaceuticals IncAMLX | 21 | Buy | $20.00 | +33.51% | Maintains | 4 months ago |
Alector IncALEC | 11 | Buy | $5.00 | +110.08% | Maintains | 5 months ago |
United Therapeutics CorpUTHR | 15 | Buy | $500.00 | -6.68% | Maintains | 6 months ago |
Biogen IncBIIB | 19 | Buy | $194.00 | +2.97% | Maintains | 7 months ago |
Fulcrum Therapeutics IncFULC | 16 | Buy | $12.00 | +49.81% | Upgrades | 7 months ago |
Candel Therapeutics IncCADL | 1 | Buy | $23.00 | +350.10% | Assumes | 8 months ago |
Kymera Therapeutics IncKYMR | 8 | Buy | $60.00 | -29.06% | Maintains | 8 months ago |
Acadia Pharmaceuticals IncACAD | 19 | Buy | $32.00 | +41.97% | Reiterates | 8 months ago |
Vertex Pharmaceuticals IncVRTX | 21 | Buy | $550.00 | +10.18% | Reiterates | 9 months ago |
Insmed IncINSM | 16 | Buy | $120.00 | -16.58% | Maintains | 9 months ago |
Pepgen IncPEPG | 12 | Buy | $8.00 | +29.87% | Maintains | 9 months ago |
Savara IncSVRA | 13 | Hold | $2.00 | -64.35% | Downgrades | 9 months ago |
Liquidia CorpLQDA | 13 | Buy | $35.00 | -9.86% | Maintains | 9 months ago |
Vigil Neuroscience IncVIGL | 14 | Hold | $8.00 | -0.62% | Downgrades | 9 months ago |
Prothena Corp Public Ltd CoPRTA | 17 | Buy | $14.00 | +43.30% | Maintains | 9 months ago |
Stoke Therapeutics IncSTOK | 14 | Buy | $35.00 | -8.74% | Maintains | 10 months ago |
Annexon IncANNX | 15 | Buy | $14.00 | +130.26% | Maintains | 10 months ago |
Structure Therapeutics IncGPCR | 5 | Buy | $75.00 | +28.82% | Maintains | 10 months ago |
Avidity Biosciences IncRNAM | 5 | Buy | $68.00 | +361.02% | Maintains | 10 months ago |
Dyne Therapeutics IncDYN | 11 | Buy | $38.00 | +92.11% | Maintains | 10 months ago |
Keros Therapeutics IncKROS | 14 | Buy | $25.00 | +115.89% | Maintains | 10 months ago |
Denali Therapeutics IncDNLI | 18 | Buy | $32.00 | +49.32% | Maintains | 10 months ago |
Biocryst Pharmaceuticals IncBCRX | 8 | Buy | $30.00 | +242.86% | Reiterates | 10 months ago |
Dbv Technologies SaDBVT | 11 | Buy | $16.00 | -32.03% | Maintains | 10 months ago |
Arvinas IncARVN | 18 | Buy | $24.00 | +73.54% | Maintains | 10 months ago |
Blueprint Medicines CorpBPMC | 16 | Buy | $135.00 | +4.28% | Reiterates | 10 months ago |
Ac Immune SaACIU | 15 | Buy | $12.00 | +294.74% | Maintains | 10 months ago |
Palvella Therapeutics IncPVLA | 6 | Buy | $38.00 | -73.26% | Reiterates | 10 months ago |
Neurocrine Biosciences IncNBIX | 17 | Buy | $168.00 | +29.37% | Maintains | a year ago |
Novabridge BiosciencesNBP | 12 | Buy | $7.00 | +116.05% | Maintains | a year ago |
Acumen Pharmaceuticals IncABOS | 11 | Buy | $11.00 | +227.38% | Maintains | a year ago |
Zentalis Pharmaceuticals IncZNTL | 18 | Buy | $10.00 | +226.80% | Reiterates | a year ago |
Wave Life Sciences LtdWVE | 12 | Buy | $22.00 | +60.00% | Reiterates | a year ago |
Sutro Biopharma IncSTRO | 15 | Hold | $20.00 | -21.35% | Downgrades | a year ago |
Proqr Therapeutics NvPRQR | 11 | Buy | $12.00 | +566.67% | Maintains | a year ago |
Foghorn Therapeutics IncFHTX | 14 | Buy | $13.00 | N/A | Reiterates | a year ago |
Protara Therapeutics IncTARA | 14 | Buy | $23.00 | N/A | Reiterates | a year ago |
Kamada LtdKMDA | 10 | Buy | $11.00 | N/A | Reiterates | a year ago |
Tscan Therapeutics IncTCRX | 13 | Buy | $15.00 | N/A | Reiterates | a year ago |
Merus NvMRUS | 16 | Buy | $85.00 | N/A | Reiterates | a year ago |
Catalyst Pharmaceuticals IncCPRX | 14 | Buy | $35.00 | N/A | Reiterates | a year ago |
Corbus Pharmaceuticals Holdings IncCRBP | 7 | Buy | $75.00 | N/A | Reiterates | a year ago |
Syros Pharmaceuticals IncSYRS | 16 | Hold | $1.00 | N/A | Downgrades | a year ago |
Unity Biotechnology IncUNBX | 7 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
C4 Therapeutics IncCCCC | 6 | Buy | $7.00 | N/A | Maintains | 2 years ago |
Deciphera Pharmaceuticals IncDCPH | 10 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Pulmatrix IncPULM | 5 | Buy | $10.00 | N/A | Reiterates | 3 years ago |
Theseus Pharmaceuticals IncTHRX | 5 | Buy | $9.00 | N/A | Maintains | 3 years ago |
Bellerophon Therapeutics IncBLPH | 4 | Buy | $2.00 | N/A | Maintains | 3 years ago |
Bellus Health IncBLU | 5 | Buy | $20.00 | N/A | Reiterates | 3 years ago |
Seagen IncSGEN | 5 | Buy | $180.00 | N/A | Reiterates | 3 years ago |
Lite Strategy IncLITS | 3 | Buy | $40.00 | N/A | Maintains | 3 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Buy | $150.00 | N/A | Reiterates | 3 years ago |
Epizyme IncEPZM | 4 | Buy | $6.00 | N/A | Maintains | 4 years ago |
Rubius Therapeutics IncRUBY | 3 | Buy | $8.00 | N/A | Maintains | 4 years ago |
Eloxx Pharmaceuticals IncELOX | 5 | Hold | $20.00 | N/A | Maintains | 4 years ago |
Amarin Corp PLCAMRN | 1 | Hold | $60.00 | N/A | Downgrades | 4 years ago |
Global Blood Therapeutics IncGBT | 2 | Buy | $65.00 | N/A | Maintains | 4 years ago |
Aldeyra Therapeutics IncALDX | 1 | Buy | $15.00 | N/A | Assumes | 4 years ago |
Aprea Therapeutics IncAPRE | 3 | Hold | $40.00 | N/A | Maintains | 4 years ago |
Disc Medicine IncIRON | 2 | Hold | $2.00 | N/A | Downgrades | 4 years ago |
Quince Therapeutics IncQNCX | 4 | Buy | $15.00 | N/A | Maintains | 4 years ago |
Opus Genetics IncIRD | 1 | Buy | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Kineta IncKANT | 1 | Buy | $39.00 | N/A | Initiates Coverage On | 5 years ago |
Translate Bio IncTBIO1 | 3 | Buy | $504.00 | N/A | Maintains | 5 years ago |
Aimmune Therapeutics IncAIMT | 2 | Hold | $15.00 | N/A | Reiterates | 6 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Buy | $75.00 | N/A | Reiterates | 6 years ago |
Concert Pharmaceuticals IncCNCE | 3 | Buy | $26.00 | N/A | Maintains | 8 years ago |
Steadymed LtdSTDY | 1 | Buy | $15.00 | N/A | Reiterates | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.